Four Directions Education And Behavior Consulting Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 215 1/2 E Colorado Ave 3a, Telluride, CO 81435 Phone: 970-708-1217 |
Map And The Mirror Counseling, Llc Clinic - Adult Mental Health Medicare: Medicare Enrolled Practice Location: 911 Two Rivers Dr, Telluride, CO 81435 Phone: 225-571-4404 |
Southwest Colorado Mental Health Center Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 238 E. Colorado Ave, Second Floor, Suite 9, Telluride, CO 81435 Phone: 970-252-3200 Fax: 970-369-1261 |
Brighter Day Health Llc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 100 W Colorado Ave, Suite 240f, Telluride, CO 81435 Phone: 713-581-8792 Fax: 713-481-0240 |
Denise E Gendreau Lcsw Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 100 West Colorado Avenue, Suite 227, Telluride, CO 81435 Phone: 970-316-1994 |
Nancy O. Read, Phd, Licensed Psychologist, Pllc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 100 W. Colorado Ave, Suite 240f, Telluride, CO 81435 Phone: 218-355-0536 |
Treeline Therapy, Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 234 N Willow Street, Telluride, CO 81435 Phone: 970-596-6979 |
News Archive
GenVault Corporation today announced that Berkeley HeartLab, a subsidiary of Celera Corporation, has adopted GenTegra DNA to preserve and store diagnostic samples for genetic testing related to the management of cardiovascular disease.
New research by University of New Hampshire exercise scientists confirms that a low-tech, easy-to-administer test is an effective tool for gauging exercise intensity, but that it does not correspond as neatly as previously assumed to other more objective tests.
Researchers in the UK have developed a high-throughput standardizable assay that accurately detects T cell responses to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.
A.I. researchers at Stevens Institute of Technology have developed a system that can detect when a person is eating and calculate how many carbohydrates they are consuming with unprecedented accuracy and speed.
› Verified 7 days ago